Disclosure Plus

ESTaid Decides on 5-to-1 Stock Consolidation

Park Jung-Soo
2026-07-14 15:23:32
[Edaily Reporter Park Jung-Soo ] ESTaid(239340)announced on the 14th that it has decided to consolidate five common shares into one. The par value per common share will increase from 100 won to 500 won, and the total number of issued shares will decrease from 26,979,634 to 5,395,926. The general shareholders’ meeting is scheduled for the 29th, and the effective date for the new shares is September 1. The new shares will be listed on September 21. Accordingly, trading in the company’s shares will be suspended from August 28 through September 18. The company stated, “We are conducting this stock consolidation to stabilize the stock price and enhance corporate value by maintaining an appropriate number of shares in circulation.”

Economy

Corporation

IT·Science

Economy

[VC's Pick] Space, Robotics, Materials… Money Flows into High-Tech Industry Startups

This week (July 27–31), startups in various fields—including materials, components, and robotics—secured investments from venture capital (VC) firms and accelerators (ACs). In particular, “MID,” a com…
2026-08-01 10:01:04

Corporation

[The Biomarker Money Game] “Liquid Biopsy,” Essential for Precision Medicine, Also Used in New Drug Development… Commercial Potential on the Rise

Liquid biopsy—a method of diagnosing cancer using only bodily fluids such as blood—has established itself as an essential technology in precision medicine and is expanding its scope of application to …
2026-08-01 08:07:01

IT·Science

SkyLabs Aims for KOSDAQ… The Global Bidding War for K-Bio Contracts Unfolds in Seoul [Bio Monthly Roundup]

(Graphic: E-Daily Reporter Kim Jeong-hoon) In August, the major events in South Korea’s pharmaceutical and biotech industry include the KOSDAQ listing of digital healthcare company SkyLabs and a s…
2026-08-01 08:01:03